Clinical Trial Update: A Phase I-II Study of Novel Oncolytic Virus VG161 Via Intravesical Instillation for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update covers the completion of a Phase I/II study evaluating intravesical VG161, an oncolytic virus, for BCG-unresponsive non-muscle-invasive bladder canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• VG161

Snippet

Sponsor: Ding-Wei Ye | Conditions: NMIBC | Phase 1, Phase 2 | Status: COMPLETED